Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A low-molecular-weight angiogenic factor in cat retina.

Literature DB >> 7066267

A low-molecular-weight angiogenic factor in cat retina.

R D Kissun, C R Hill, A Garner, P Phillips, S Kumar, J B Weiss.

Abstract

A low-molecular-weight angiogenic factor has been isolated from healthy adult cat retinas. The factor, which has been purified by diethylaminoethyl (DEAE) cellulose chromatography and affinity chromatography, stimulates neovascularisation of the chick chorioallantoic membrane and has a number of properties similar to those previously described for a tumour factor. The finding of an angiogenic factor in healthy retina and its relationship to previously described inhibitors of angiogenesis is discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1982 PMID： 7066267 PMCID： PMC1039745 DOI： 10.1136/bjo.66.3.165

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

20 in total

1. Vasoformative properties of normal and hypoxic retinal tissue.

Authors: R D Kissun; A Garner
Journal: Br J Ophthalmol Date: 1977-06 Impact factor: 4.638

2. Inhibition of neovascularization by an extract derived from vitreous.

Authors: I Preis; R Langer; H Brem; J Folkman
Journal: Am J Ophthalmol Date: 1977-09 Impact factor: 5.258

3. Photocoagulation in complications secondary to branch vein occlusion.

Authors: A E Krill; D Archer; F W Newell
Journal: Arch Ophthalmol Date: 1971-01

4. Classification and pathogenesis of proliferative sickle retinopathy.

Authors: M F Goldberg
Journal: Am J Ophthalmol Date: 1971-03 Impact factor: 5.258

5. Ocular neovascularization. The Krill memorial lecture.

Authors: P Henkind
Journal: Am J Ophthalmol Date: 1978-03 Impact factor: 5.258

6. Endothelium stimulating factor from Walker carcinoma cells. Relation to tumor angiogenic factor.

Authors: B R McAuslan; H Hoffman
Journal: Exp Cell Res Date: 1979-03-01 Impact factor: 3.905

7. Vitreous inhibition of tumor neovascularization.

Authors: S M Felton; G C Brown; N T Felberg; J L Federman
Journal: Arch Ophthalmol Date: 1979-09

8. Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum.

Authors: P Phillips; S Kumar
Journal: Int J Cancer Date: 1979-01-15 Impact factor: 7.396

9. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.

Authors: S Brem; H Brem; J Folkman; D Finkelstein; A Patz
Journal: Cancer Res Date: 1976-08 Impact factor: 12.701

10. Isolation of a tumor factor responsible for angiogenesis.

Authors: J Folkman; E Merler; C Abernathy; G Williams
Journal: J Exp Med Date: 1971-02-01 Impact factor: 14.307

10 in total

Review 1. Neovascularisation again.

Authors: R Smith
Journal: Br J Ophthalmol Date: 1990-06 Impact factor: 4.638

2. Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina.

Authors: C M Taylor; J B Weiss; R D Kissun; A Garner
Journal: Br J Ophthalmol Date: 1986-03 Impact factor: 4.638

Review 10. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.

Authors: Sara Rezzola; Alessandra Loda; Michela Corsini; Francesco Semeraro; Tiziana Annese; Marco Presta; Domenico Ribatti
Journal: Front Immunol Date: 2020-09-29 Impact factor: 7.561

10 in total

A low-molecular-weight angiogenic factor in cat retina.

1. Vasoformative properties of normal and hypoxic retinal tissue.

2. Inhibition of neovascularization by an extract derived from vitreous.

3. Photocoagulation in complications secondary to branch vein occlusion.

4. Classification and pathogenesis of proliferative sickle retinopathy.

5. Ocular neovascularization. The Krill memorial lecture.

6. Endothelium stimulating factor from Walker carcinoma cells. Relation to tumor angiogenic factor.

7. Vitreous inhibition of tumor neovascularization.

8. Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum.

9. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.

10. Isolation of a tumor factor responsible for angiogenesis.

Review 1. Neovascularisation again.

2. Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina.

3. Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea.

4. Experimental studies on the pathogenesis of retinopathy of prematurity.

5. Increased procollagenase activating angiogenic factor in the vitreous humour of oxygen treated kittens.

6. Relationship of angiogenesis factor in synovial fluid to various joint diseases.

7. Angiogenic factor in vitreous from diabetic retinopathy.

8. Extracapsular cataract extraction in diabetic eyes. The role of YAG laser capsulotomy.

9. Quantitation of angiogenesis factor in bovine retina and tumour extracts by means of radioimmunoassay.

Review 10. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.